 |
Kevin Romani, Director of Development at PME SME's, interviews Kader Thiam, VP at Transgenic Technologies, and Alain Lamproye, President of Biopharma, two companies based in the Rhone-Alps region of France — one of the most dynamic areas for the life sciences sector in Europe.
|
 |
Maria Marshall, Assistant Director of Industry and Technology at the Trade Commission of Spain, interviews Pepi Hurtado and Itazar Escudero of Insights in Life Sciences (ilS), a consulting firm with a global network of life sciences experts.
|
 |
Maria Thacker and Larry Mahan discuss the relationship between CSBI and the BIOTechnology Institute in creating awareness around STEM education and the importance of getting the industry involved in developing the next generation of biotech leadership.
|
 |
BIO helps foster connections that will benefit the biotech industry throughout the year, from Meetups, to formal 1-on-1 partnering meetings, to social gatherings.
|
 |
Andy Gogates spotlights the Rutgers MBA in Pharmaceutical Management and the Rutgers Pharmaceutical Industry Scholarship program.
|
 |
Elysium Therapeutics is a participant in the 2015 BIO Innovation Zone and a recipient of two Fast Ttrack NIH SBIR grants.
|
 |
David Brancaccio speaks with Mike May about how Scientific American determined it's list of the 100 influencers shaping the biotech industry.
|
 |
A recap of Tuesday's events, featuring FierceBiotech's breakfast panel on cancer drug R&D, the Start-up Stadium competition, Tom Brokaw's keynote session, and BIO's Cheesesteak Wars reception.
|
 |
Dr. Robin Robinson on The Biomedical Advanced Research and Development Authority's work in response to the Ebola Epidemic and the U.S. government’s efforts to partner with the biotech industry
|
 |
BIO board member and Horizon Pharma CEO Tim Walbert on his company's recent donation to the Make-a-Wish Foundation and the importance of patient advocacy in biotech
|
